Replies to post #421416 on Anavex Life Sciences Corp (AVXL)

[tredenwater2]

Essentially Anavex is set up for a threshold event. Rather like an avalanche. Nothing happening till that last show flake hits then some snow starts moving down hill, increasing in momentum and volume as it goes.

Nice analogy and spot on Steady. We might lose a few “snowflakes” along the way but I don’t think matters much as we will make up for them with blizzard like conditions soon.

At 8 years +/- we are ahead of schedule based on the “decade long” average time frame it takes to bring a drug to market. In fact, we are ahead of schedule, for multiple diseases, and after withstanding a pandemic so context is everything here. Add in the no debt and approximately 100 million shares OS at breaking point of accumulated snowflakes and we have a thunderous amount of weight that WILL start rolling.

This is the only way we can “roll”, one data set shared, one disease trial confirmation, one patent, one major employee signing, one partnership etc. at a time continuously lightly layering in the the snowball. Dr. Misslings approach imo will be scrutinized by many wondering how he ever concocted such a behemoth of a “snowball” so quietly outside of the “fair and balanced” markets view.

Happy 4rth of July to you Steady and all of our fellow American ihub members. As always pray for our country’s leaders on this day of Independence celebration.

Tred

[Gator328]

“Once 2-73 is approved and the full AD data is published, the disease mechanism proposed by Anavex will be taken far more seriously.”

I’d change it to “if 2-73 is approved…”

But your point is valid. And part of the upside is that Anavex will become, overnight, the leader in Sigma-1 knowledge and that will make the company very appealing if others decide maybe there’s something to the upstream MOA.